Lymphoproliferative disease after allogeneic stem cell transplantation—pre-emptive diagnosis by quantification of Epstein–Barr virus DNA in serum Sanna.

Lymphoproliferative disease after allogeneic stem cell transplantation—pre-emptive diagnosis by quantification of Epstein–Barr virus DNA in serum Sanna M. Aalto, Eeva Juvonen, Jussi Tarkkanen, Liisa Volin, Tapani Ruutu, Petri S. Mattila, Heli Piiparinen, Sakari Knuutila, Klaus Hedman Journal of Clinical Virology Volume 28, Issue 3, Pages (December 2003) DOI: /S (03)

Fig. 1 Time course of EBV genome loads measured by real-time PCR in consecutive sera from 12 patients succumbed of PTLD. Each line indicates the viral load (DNA copies per 1 ml serum) of an individual patient. Time of death on the right. Journal of Clinical Virology , DOI: ( /S (03) )

Fig. 2 The same EBV genome loads as in Fig. 1, plotted relative to the onset of PTLD-fever in each patient (marked as day 0). Journal of Clinical Virology , DOI: ( /S (03) )

Lymphoproliferative disease after allogeneic stem cell transplantation—pre-emptive diagnosis by quantification of Epstein–Barr virus DNA in serum Sanna.

Samankaltaiset esitykset

Esitys aiheesta: "Lymphoproliferative disease after allogeneic stem cell transplantation—pre-emptive diagnosis by quantification of Epstein–Barr virus DNA in serum Sanna."— Esityksen transkriptio:

Samankaltaiset esitykset

Projektista

Palaute

Kirjaudu sisään

Kirjaudu sisään sosiaaliverkostojen kautta:

Lymphoproliferative disease after allogeneic stem cell transplantation—pre-emptive diagnosis by quantification of Epstein–Barr virus DNA in serum Sanna.

Samankaltaiset esitykset

Esitys aiheesta: "Lymphoproliferative disease after allogeneic stem cell transplantation—pre-emptive diagnosis by quantification of Epstein–Barr virus DNA in serum Sanna."— Esityksen transkriptio:

Samankaltaiset esitykset

Projektista

Palaute